Gene: PDIA2
Official Full Name: protein disulfide isomerase family A member 2provided by HGNC
Gene Summary: This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal ER-signal sequence, two catalytically active thioredoxin (TRX) domains, two TRX-like domains and a C-terminal ER-retention sequence. The protein plays a role in the folding of nascent proteins in the endoplasmic reticulum by forming disulfide bonds through its thiol isomerase, oxidase, and reductase activity. The encoded protein also possesses estradiol-binding activity and can modulate intracellular estradiol levels. [provided by RefSeq, Sep 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20878 | PDIA2 Knockout cell line (HEK293) | Human | PDIA2 | 1:3~1:6 | Negative | Online Inquiry |
PDIA2 Gene Knockout Cell Lines represent a pioneering biological tool designed to facilitate the study of the PDIA2 gene, which encodes a protein that plays a crucial role in protein folding and quality control within the endoplasmic reticulum. This product involves the targeted disruption of the PDIA2 gene, leading to a complete knockout of its expression in cultured cells. By eliminating functional PDIA2, researchers can investigate the gene's contributions to cellular processes such as stress response, apoptosis, and various diseases, including cancer and neurodegenerative disorders.
The key mechanism of these knockout cell lines lies in the use of CRISPR-Cas9 technology, which allows precise editing of the genome to induce frameshift mutations or deletions within the PDIA2 gene. This genetic alteration enables the study of phenotypic changes associated with the loss of PDIA2 function, thus elucidating its role in cellular homeostasis and disease pathology.
From a scientific standpoint, PDIA2 Gene Knockout Cell Lines are invaluable in both research and clinical settings. They provide a robust model for understanding the molecular mechanisms of diseases related to protein misfolding and provide pathways for developing novel therapeutic strategies. Their application spans drug discovery, toxicity testing, and the elucidation of disease mechanisms, making them essential for both academic and pharmaceutical research.
Compared to alternative models, the specificity and efficiency of CRISPR-Cas9-mediated knockout yield more consistent and reproducible results. These cell lines offer researchers an indispensable resource, facilitating deeper insights into the implications of PDIA2 across various biological contexts.
The adoption of PDIA2 Gene Knockout Cell Lines allows researchers and clinicians to drive advancements in their fields through innovative experimental designs. Partnering with our company, which has a proven track record in genetic engineering and development of advanced biological products, assures users of comprehensive support and high-quality reagents optimized for their research needs. By choosing our cell lines, professionals are empowered to uncover new scientific knowledge with greater speed and precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.